EUVIMEDEUVIMED entdecken
Crossref

Tissue Factor Driven Coagulation and Inflammation in Lung Injury: Insights From In Vitro and In Vivo Models

Aleena Varughese, Akarsha Balnadupete, Fathimath Muneesa Moideen, Jeena Thrikkandiyoor Madambath, Rakshitha Charavu, Kirana Mugaranja, Punya Sunil, D M Dhivya Dharsini, A ArunBharathi, Yashodhar P Bhandary iD

IUBMB Life · 2025

DOI: 10.1002/iub.70060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Aleena Varughese und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology and Molecular Genetics Division, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India. Hauptthemen laut MEDLINE: Thromboplastin, Blood Coagulation, Lung Injury, Pulmonary Fibrosis. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Yenepoya Research Center, Yenepoya (Deemed to be University).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung injury and fibrosis involve a complex interplay between inflammation and coagulation, with tissue factor (TF/CF‐III/Thromboplastin/CD142) acting as a crucial mediator. Despite its known role in initiating the extrinsic coagulation cascade, TF's contribution to fibrin deposition in lung injury remains underexplored. This study examines the dysregulation of the extrinsic coagulation cascade and its pathological implications in lung injury, contributing to the progression of pulmonary fibrosis (PF). Utilizing bleomycin (BLM), transforming growth factor‐β (TGF‐β), and TF models, we systematically investigate coagulation‐driven inflammatory responses in lung pathology. By integrating in vitro (A549 and Beas2b epithelial cell models) and in vivo (C57BL/6 murine models) approaches, this study elucidates TF‐mediated molecular mechanisms driving inflammation, fibrin deposition, endothelial dysfunction, and fibrotic remodeling. Protein‐protein interaction (PPI) network analysis highlights functional associations between coagulation factors (CFs) and inflammatory mediators, reinforcing their involvement in lung homeostasis. Also, gene enrichment analysis identifies key biological processes, including coagulation, fibrinolysis, and immune activation, emphasizing their role in disease progression. In A549 and Beas2b epithelial cells, CF‐III, CF‐VII, and CF‐X expression increased significantly, with A549 cells exhibiting a heightened pro‐coagulant response. Elevated IL‐6, TNF‐α, and IL‐1β levels suggest an inflammatory amplification tied to TF activation. Immunofluorescence analysis demonstrates marked TF upregulation and TNF‐α activation, reinforcing the interplay between coagulation pathways and inflammatory cytokine signaling. Histological assessments (H&E, and Masson Trichrome [MT] staining) in murine lung tissues confirm fibrotic and inflammatory changes, reinforcing TF's pathogenic role. Our findings establish TF as a key molecular driver of thrombo‐inflammatory lung injury, providing potential therapeutic targets to mitigate fibrosis and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThromboplastinBlood CoagulationLung InjuryPulmonary FibrosisInflammationAnimalsHumansMiceBleomycinMice, Inbred C57BLDisease Models, AnimalA549 CellsTransforming Growth Factor betaFibrinLung

Stichwörter der Autor:innen

TGF‐βbleomycincoagulation cascadelung injury

Substanzen

ThromboplastinBleomycinTransforming Growth Factor betaFibrin

Autor:innen und Institutionen

  • Cell Biology and Molecular Genetics Division, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India.
  • University of Texas Health Science Centre at Tyler, Tyler, Texas, USA.
  • IQRAA Centre for Research and Development, IQRAA International Hospital and Research Centre, Calicut, Kerala, India.
  • Division of Data Analytics, Bioinformatics and Structural Biology (DABS), Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
  • Department of Biotechnology, Alagappa University Karaikudi, Tamil Nadu, India.
  • Specialized Research Unit, Yenepoya Medical College and Hospital, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.

ORCID-Profile: Yashodhar P Bhandary

Förderung

  • Yenepoya Research Center, Yenepoya (Deemed to be University)

Zitieren

APA

Varughese, A., Balnadupete, A., Moideen, F. M., Madambath, J. T., Charavu, R., Mugaranja, K., Sunil, P., Dhivya Dharsini, D. M., ArunBharathi, A., & Bhandary, Y. P. (2025). Tissue Factor Driven Coagulation and Inflammation in Lung Injury: Insights From In Vitro and In Vivo Models. IUBMB Life. https://doi.org/10.1002/iub.70060

Vancouver

Varughese A, Balnadupete A, Moideen FM, Madambath JT, Charavu R, Mugaranja K, et al. Tissue Factor Driven Coagulation and Inflammation in Lung Injury: Insights From In Vitro and In Vivo Models. IUBMB Life. 2025. doi:10.1002/iub.70060

BibTeX
@article{Varughese2025,
  author = {Varughese, Aleena and Balnadupete, Akarsha and Moideen, Fathimath Muneesa and Madambath, Jeena Thrikkandiyoor and Charavu, Rakshitha and Mugaranja, Kirana and Sunil, Punya and Dhivya Dharsini, D M and ArunBharathi, A and Bhandary, Yashodhar P},
  title = {Tissue Factor Driven Coagulation and Inflammation in Lung Injury: Insights From In Vitro and In Vivo Models},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.70060}
}
Kostenlos starten →